AMANDA CANIZALES: Open Payments
NPI 1114543865 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,536 in 199 payments from 30 companies in 2025. Trend: 2023 $1,561 · 2024 $4,878 · 2025 $3,536
Food & beverage: $3,536
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 89 | $1,410 |
| Eisai Inc. | 9 | $233 |
| ARGENX US, INC. | 7 | $168 |
| UCB, Inc. | 15 | $145 |
| ACADIA Pharmaceuticals Inc | 9 | $138 |
| Lilly USA, LLC | 6 | $135 |
| Vanda Pharmaceuticals Inc. | 4 | $109 |
| Neurocrine BioSciences, Inc. | 4 | $100 |
| EMD Serono, Inc. | 4 | $97 |
| Lundbeck LLC | 5 | $87 |
Products named: BOTOX, QULIPTA, Leqembi, VYVGART HYTRULO, UBRELVY, NUPLAZID, KISUNLA, PONVORY.
Industry payments across AZ — which companies pay providers there.
